Heart attack

October 20, 2018

A probiotic way to insulate your heart against cardiac dysfunction: Probiotic Lactobacillus sakei-based adjuvant therapy for cardiac hypertrophy and fibrosis: Probiotic Lactobacillus sakei OK67 decreases Mir-29 expression, activates Wnt- signaling and its components GSK3B, ICAT/CTNNBIP1, HBP1, and GLIS2, attenuates pathologic hypertrophy, inhibits fibrosis of the heart tissue, and improves cardiac function via upregulation of its target gene, 20/October/2018, 5.35 pm

Introduction: What they say:   A recent study from the Institute of Pharmacology and Toxicology, Technical University Munich (TUM), 80802, Munich, Germany; DZHK (German Center for Cardiovascular […]
October 20, 2018

A probiotic way to protect your heart from cardiac diseases and cardiac ageing: Probiotic Lactobacillus Sakei OK67 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of PNUTS, 20/October/2018, 4.52 pm

What they say:  A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March  2013 issue of of […]
October 18, 2018

The tiny probiotic may safeguard your heart against cardiac dysfunction: Probiotic Lactobacillus pentosus var.plantarum C29-based therapy for cardiomyocyte proliferation and heart regeneration: Probiotic Lactobacillus pentosus var.plantarum C29 decreases tumor suppressor Mir-128 and cyclin-dependent kinase inhibitor p27 expression, increases SUZ12 expression, increases Cyclin E and CDK2 expression, promotes proliferation/re-entry of postnatal/adult cardiomyocytes, attenuates fibrosis, ameliorates cardiac dysfunction, and promotes heart repair in response to myocardial infarction, via up-regulation of its target gene, 18/Ocotober/2018, 11.01 pm

Introduction: What they say: A recent study from Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA; Key Laboratory […]
October 11, 2018

A probiotic-based Cardiac rejuvenation therapy: Probiotic Lactobacillus Brevis suppresses tumor suppressor INK4a/p16 expression, and inhibits dilated cardiomyopathy via upregulation of its target gene, 12/October/2018, 2.04 am

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: A probiotic-based Cardiac rejuvenation therapy: Probiotic Lactobacillus Brevis suppresses tumor suppressor INK4a/p16 expression, and inhibits dilated cardiomyopathy […]